Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Neuen BL, Heerspink HJL, Perkovic V, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Jongs N, Smeijer JD, Brinker M, Ahlers C, Lage A, Horvat-Bröcker A, Schloemer P, Eissing T, Dayoub R, Lawatscheck R, Agarwal R, FIND-CKD, FIDELIO-DKD and FIGARO-DKD Investigators

Open source

DOI
10.1016/s0140-6736(26)01009-3
Published
2026 Jun 13
Container
Lancet (London, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01009-3,
  title = {Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).},
  author = {Neuen BL and Heerspink HJL and Perkovic V and Cherney DZI and Lam CSP and Tuttle KR and Wanner C and Sarafidis P and Anker SD and Filippatos G and Pitt B and Rossing P and Ruilope LM and Jongs N and Smeijer JD and Brinker M and Ahlers C and Lage A and Horvat-Bröcker A and Schloemer P and Eissing T and Dayoub R and Lawatscheck R and Agarwal R and FIND-CKD, FIDELIO-DKD and FIGARO-DKD Investigators},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01009-3},
  url = {https://doi.org/10.1016/s0140-6736(26)01009-3}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).
AU  - Neuen BL
AU  - Heerspink HJL
AU  - Perkovic V
AU  - Cherney DZI
AU  - Lam CSP
AU  - Tuttle KR
AU  - Wanner C
AU  - Sarafidis P
AU  - Anker SD
AU  - Filippatos G
AU  - Pitt B
AU  - Rossing P
AU  - Ruilope LM
AU  - Jongs N
AU  - Smeijer JD
AU  - Brinker M
AU  - Ahlers C
AU  - Lage A
AU  - Horvat-Bröcker A
AU  - Schloemer P
AU  - Eissing T
AU  - Dayoub R
AU  - Lawatscheck R
AU  - Agarwal R
AU  - FIND-CKD, FIDELIO-DKD and FIGARO-DKD Investigators
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01009-3
UR  - https://doi.org/10.1016/s0140-6736(26)01009-3
ER  - 

APA

BL, N., HJL, H., V, P., DZI, C., CSP, L., KR, T., C, W., P, S., SD, A., G, F., B, P., P, R., LM, R., N, J., JD, S., M, B., C, A., A, L., A, H., P, S., T, E., R, D., R, L., R, A., & Investigators, F. F. A. F. (2026). Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01009-3

Source records